4-(1,3-dioxolan-2-yl)-6-benzyloxyhexan-1-ol | 188125-36-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 4-(1,3-dioxolan-2-yl)-6-benzyloxyhexan-1-ol
• 英文别名: 4-(1,3-dioxolan-2-yl)-6-phenylmethoxyhexan-1-ol
• CAS: 188125-36-2
• 化学式: C₁₆H₂₄O₄
• 分子量: 280.364
• InChiKey: TZYYNYMOIVZIOB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  20
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  47.9
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-(1,3-dioxolan-2-yl)-6-benzyloxyhexan-1-ol 在 草酰氯 、 二甲基亚砜 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以81%的产率得到4-(1,3-dioxolan-2-yl)-6-benzyloxyhexanal
  参考文献：
  名称：

  Total syntheses of racemic albifloranine and its anti-addictive congeners, including 18-methoxycoronaridine

  摘要：

  Condensation of methyl 3-benzyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole-5-carboxylate (12) with 4-(1,3-dioxolan-2-yl)-6-benzylaxyhexanal (11a) provided the tetracyclic intermediates methyl (3aSR,4RS,11bRS)-3-benzyl-2,3,3a,4,5,7-hexahydro-4-[2-zeta-(1,3-dioxalan-2-yl)-4-benzyloxy)-1-butyl]-1H-pyrrolo[2,3-d]carbazole-6-carboxylates (14a,15a), which were further elaborated to afford racemic albifloranine (3). The first total synthesis of albifloranine was completed in 13 steps, with an overall 7% yield. Ester and ether derivatives of albifloranine were synthesized for evaluation as anti-addictive agents. Among these, 18-methoxycoronaridine (20b) stands out as a nontoxic agent that significantly reduces demand for morphine, cocaine, nicotine and alcohol in rats. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(99)00513-x
• 作为产物：
  描述：

  烯丙基丙二酸二乙酯 在 对甲苯磺酸 lithium aluminium tetrahydride 、 草酰氯 、 dimethyl sulfide borane 、 sodium hydride 、 二甲基亚砜 、 三乙胺 、 lithium chloride 作用下， 以 四氢呋喃 、 乙醚 、 二氯甲烷 、 水 、 二甲基亚砜 、 N,N-二甲基甲酰胺 、 苯 为溶剂， 反应 34.5h， 生成 4-(1,3-dioxolan-2-yl)-6-benzyloxyhexan-1-ol
  参考文献：
  名称：

  Total syntheses of racemic albifloranine and its anti-addictive congeners, including 18-methoxycoronaridine

  摘要：

  Condensation of methyl 3-benzyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole-5-carboxylate (12) with 4-(1,3-dioxolan-2-yl)-6-benzylaxyhexanal (11a) provided the tetracyclic intermediates methyl (3aSR,4RS,11bRS)-3-benzyl-2,3,3a,4,5,7-hexahydro-4-[2-zeta-(1,3-dioxalan-2-yl)-4-benzyloxy)-1-butyl]-1H-pyrrolo[2,3-d]carbazole-6-carboxylates (14a,15a), which were further elaborated to afford racemic albifloranine (3). The first total synthesis of albifloranine was completed in 13 steps, with an overall 7% yield. Ester and ether derivatives of albifloranine were synthesized for evaluation as anti-addictive agents. Among these, 18-methoxycoronaridine (20b) stands out as a nontoxic agent that significantly reduces demand for morphine, cocaine, nicotine and alcohol in rats. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(99)00513-x

文献信息

• Ibogamine congeners
  申请人：Albany Medical College

  公开号：US06211360B1

  公开（公告）日：2001-04-03

  The present invention is directed to compounds having formula (1), wherein n is from 0 to 8; R1 is CH2OH, CH(OH)R5, CH2OR5, CO2R5, C(O)NH2, C(I)NHR5, C(O)NR5R6, C(O)NHNH2, C(O)NHNHR5, C(O)NHNR5R6, C(O)NR5NH2, C(O)NR5NHR6, C(O)NR5NR6R7, C(O)NHNH(C(O)R5), C(O)NHNR5(C(O)R6) C(O)NR5NH(C(O)R6), C(O)NR5NR6(C(O)R7), CN, or C(O)R5; R2 is H, unsubstituted or substituted alkyl, YH, YR8, YC(O)R8, C(O)YR8, C(O)NH2, C(O)NHR8, C(O)NR8R9, NH2, NHR8, NR8R9, NHC(O)R8, or NR8C(O)R9; R3 and R4 are the same or different and are selected from the group consisting of H, halogens, unsubstituted or substituted alkyl, OH, OR10, NH2, NHR10, NR10R11, NHC(O)R10, or NR10C(O)R11; R5, R6, R7, R8, R9, R10, and R11 are the same or different and are selected from the group consisting of unsubstituted alkyl and substituted alkyl and substituted alkyl; R12 is selected from the group consisting of J, unsubstituted alkyl, and substituted alkyl; and Y is O or S; provided that when n is O, R2 is selected from the group consisting of H, substituted alkyl, and unsubstituted alkyl; and pharmaceutically acceptable salts thereof. The compounds are useful in the treatment of subjects addicted to opiates and stimulants and have reduced side effects relative to other ibogamine congeners.

  本发明涉及具有公式（1）的化合物，其中n为0到8；R1为CH2OH，CH（OH）R5，CH2OR5，CO2R5，C（O）NH2，C（I）NHR5，C（O）NR5R6，C（O）NHNH2，C（O）NHNHR5，C（O）NHNR5R6，C（O）NR5NH2，C（O）NR5NHR6，C（O）NR5NR6R7，C（O）NHNH（C（O）R5），C（O）NHNR5（C（O）R6），C（O）NR5NH（C（O）R6），C（O）NR5NR6（C（O）R7），CN或C（O）R5；R2为H，未取代或取代的烷基，YH，YR8，YC（O）R8，C（O）YR8，C（O）NH2，C（O）NHR8，C（O）NR8R9，NH2，NHR8，NR8R9，NHC（O）R8或NR8C（O）R9；R3和R4相同或不同，并选择自H，卤素，未取代或取代的烷基，OH，OR10，NH2，NHR10，NR10R11，NHC（O）R10或NR10C（O）R11的群组中；R5，R6，R7，R8，R9，R10和R11相同或不同，并选择自未取代的烷基和取代的烷基和取代的烷基的群组中；R12选择自J，未取代的烷基和取代的烷基的群组中；Y为O或S；前提是当n为0时，R2选择自H，取代烷基和未取代烷基的群组中；以及其药学上可接受的盐。这些化合物在治疗对阿片类和兴奋剂上瘾的受试者方面是有用的，并且相对于其他伊博加明同系物具有减少的副作用。
• US6211360B1
  申请人：——

  公开号：US6211360B1

  公开（公告）日：2001-04-03
• Total syntheses of racemic albifloranine and its anti-addictive congeners, including 18-methoxycoronaridine
  作者：Upul K. Bandarage、Martin E. Kuehne、Stanley D. Glick

  DOI：10.1016/s0040-4020(99)00513-x

  日期：1999.7

  Condensation of methyl 3-benzyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole-5-carboxylate (12) with 4-(1,3-dioxolan-2-yl)-6-benzylaxyhexanal (11a) provided the tetracyclic intermediates methyl (3aSR,4RS,11bRS)-3-benzyl-2,3,3a,4,5,7-hexahydro-4-[2-zeta-(1,3-dioxalan-2-yl)-4-benzyloxy)-1-butyl]-1H-pyrrolo[2,3-d]carbazole-6-carboxylates (14a,15a), which were further elaborated to afford racemic albifloranine (3). The first total synthesis of albifloranine was completed in 13 steps, with an overall 7% yield. Ester and ether derivatives of albifloranine were synthesized for evaluation as anti-addictive agents. Among these, 18-methoxycoronaridine (20b) stands out as a nontoxic agent that significantly reduces demand for morphine, cocaine, nicotine and alcohol in rats. (C) 1999 Elsevier Science Ltd. All rights reserved.